PubAg

Main content area

Glutamate affects the production of epoxyeicosanoids within the brain: the up-regulation of brain CYP2J through the MAPK-CREB signaling pathway

Author:
Liu, Mingzhou, Zhu, Quanfei, Wu, Jinhua, Yu, Xuming, Hu, Mingbai, Xie, Xianfei, Yang, Zheqiong, Yang, Jing, Feng, Yu-Qi, Yue, Jiang
Source:
Toxicology 2017
ISSN:
0300-483X
Subject:
acids, adults, antagonists, astrocytes, brain stem, cerebellum, cyclic AMP, dose response, frontal lobe, gene overexpression, glutamate receptors, glutamic acid, hippocampus, messenger RNA, metabolome, mitogen-activated protein kinase, neurodegenerative diseases, neurotransmitters, rats, signal transduction, subcutaneous injection
Abstract:
Glutamate is the major excitatory neurotransmitter in the brain, and chronic glutamate excitotoxicity has been thought to be involved in numerous neurodegenerative diseases. We investigated the effects of glutamate at concentrations lower than the usual extrasynaptic concentrations on the production of epoxyeicosanoids mediated by brain CYP2J. Glutamate increased CYP2J2 mRNA levels in astrocytes in a dose-dependent manner, while an antagonist of the metabotropic glutamate receptor subtype 5 (mGlu5 receptor) attenuated the glutamate-induced increases in CYP2J2 levels by glutamate. Glutamate increased the binding of cAMP response element-binding protein (CREB) with the CYP2J2 promoter, and the inhibition of the MAPK signaling pathway (ERK1/2, p38, and JNK) decreased the binding of CREB with the CYP2J2 promoter following the glutamate treatment. CREB activated the CYP2J2 promoter located at −1522 to −1317bp, and CREB overexpression significantly increased CYP2J2 mRNA levels. The CYP2J2 and mGlu5 mRNA levels were higher in the frontal cortex, hippocampus, cerebellum, and brainstem in adult rats that received a subcutaneous injection of monosodium L-glutamate at 1, 3, 5, and 7days of age. The data from the partial least-squares-discriminant analysis showed the epoxyeicosanoid profile of the hippocampus from the cerebellum, brain stem, and frontal cortex. The sum of the epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatrienoic acids (DHETs) was increased by 1.16-fold, 1.18-fold, and 1.19-fold in the frontal cortex, cerebellum, and brain stem, respectively, in rats treated with monosodium L-glutamate compared with the control group. The results suggest that brain CYP2J levels and CYP2J-mediated epoxyeicosanoid production can be regulated by extrasynaptic glutamate. The glutamate receptors expressed in astrocytes may mediate the regulation of drug-metabolizing enzymes and the metabolome of endogenous substances by glutamate.
Agid:
5639038